Stocktoria

Genprex, Inc. GNPX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-03-29 · LEI

Genprex, Inc. statistics & valuation

Market cap$5.4M
P / B0.7×
Return on capital-194.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-254.30% -773.30% -139.30% -352.40% -58.00% -50.10% -106.60% -416.10% -1303.00% -203.80% 2016201720182019202020212022202320242025
Shares outstanding
11.4M 11.7M 15.2M 19.3M 43.1M 47.9M 1.2M 1.5M 217234 3.3M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-216.30% -263.10% -133.50% -301.50% -57.20% -48.20% -94.60% -289.20% -511.90% -159.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-159.7%-511.9%-289.2%-94.6%-48.2%-57.2%-301.5%-133.5%-263.1%-216.3%
Return on equity-203.8%-1303.0%-416.1%-106.6%-50.1%-58.0%-352.4%-139.3%-773.3%-254.3%
Current ratio3.840.832.317.6424.6961.475.8322.810.235.74

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.